Updated September 24, 2026 with the NHS-Galleri paper and the FDA panel vote. The deadliest cancers for men over 50, by age band; what half a century of progress actually bought; and the one screening decision where three expert bodies still disagree. By Gunnar · Not medical advice · Every number links to its source
A hacked small-town government website is ranking on Google for real peptide brands and redirecting searchers into a WhatsApp sales operation.
Updated September 26, 2026 with Lilly’s first Phase 1 safety data and a note that the drug is dosed weekly, not monthly. Brenipatide side effects: thirteen registered trials, ten conditions, and not one has reported. Here is what is actually known. I take tirzepatide every Friday, so I know exactly what a GLP-1 does to
My calcium score is zero and my ApoB was flagged high. When the 2026 guideline lets a zero defer a statin, the four exceptions, how long a zero lasts, and what I did.
I read the study behind the alcohol and cancer deaths headlines. Since 1990, the national rate rose modestly — men 55 and older saw by far the sharpest increase.
Both machines live in my garage. With a bone-on-bone knee, the bike gets most of the work, even though the one implant study that measured both found less knee force on the rower.
Pelacarsen missed its primary endpoint in the Lp(a)HORIZON trial. Here’s what’s actually known, what two doctors think happened, and why I’m putting my own effort back into LDL and ApoB instead of waiting on an Lp(a) drug.
I paid Lilly’s self-pay price for Zepbound for months, and retatrutide has no announced price yet, so here is what Lilly’s own price ladders imply.
CagriSema has no announced brand name as of September 4, 2026. Novo Nordisk owns eleven invented names it could use, and it bought the matching web address for only six of them.
CagriSema is not approved, so Medicare does not cover it. Here are the three routes after the FDA decides: the $50 Medicare GLP-1 Bridge, regular Part D, or the CagriSema cost without insurance.
